Results 91 to 100 of about 637,976 (296)
Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection
Background In the Strategies for Management of Anti-Retroviral Therapy trial, all-cause mortality was higher for participants randomized to intermittent, CD4-guided antiretroviral treatment (ART) (drug conservation [DC]) than continuous ART (viral ...
Lewis H. Kuller+11 more
semanticscholar +1 more source
Lanthanide ytterbium ions are introduced into Bi2WO6 nanosheets to boost ROS generation under US stimulation. These ytterbium‐doped Bi2WO6 nanosheets serve as efficient sonosensitizers, enabling broad‐spectrum bacterial eradication. To improve biocompatibility for in vivo sonodynamic therapy, the sonosensitizers are integrated into hydrogel matrix ...
Xinyue Lao+6 more
wiley +1 more source
IntroductionUnfolded Von Willebrand Factor (VWF) is increased in thrombotic pathologies such as myocardial infarction. Unfolded VWF mediates the binding of platelets without the need for collagen.
Romy de Laat-Kremers+9 more
doaj +1 more source
Coagulation abnormalities and thrombosis in patients with COVID-19
M. Levi, J. Thachil, T. Iba, J. Levy
semanticscholar +1 more source
Overview of the coagulation system
Coagulation is a dynamic process and the understanding of the blood coagulation system has evolved over the recent years in anaesthetic practice. Although the traditional classification of the coagulation system into extrinsic and intrinsic pathway is ...
S. Palta, R. Saroa, A. Palta
semanticscholar +1 more source
Engineering Highly Cellularized Living Materials via Mechanical Agitation
A mechanical agitation strategy is developed to engineer highly cellularized living materials, achieving cell densities of up to 1 billion cells per milliliter. By precisely tuning properties such as stiffness and toughness in blood clots, the approach is validated in both in vitro and in vivo studies.
Aram Bahmani+9 more
wiley +1 more source
A clinical survey of bleeding, thrombosis, and blood product use in decompensated cirrhosis patients
Background. The relative incidence of bleeding and thrombotic events and the use of blood products in hospitalized cirrhosis patients have not been widely reported.
Neeral L. Shah+2 more
doaj
THE EFFECT OF TEMPERATURE ON BLOOD COAGULATION TIME [PDF]
Sutherland Simpson, A. T. Rasmussen
openalex +1 more source
This review highlights emerging bioengineering strategies for treating neointimal hyperplasia in the peripheral vasculature, focusing on approaches that promote re‐endothelialization, modulate smooth muscle cell phenotype, reduce inflammation, mitigate oxidative stress, and optimize biomechanical compliance.
Nikita Wilson John+5 more
wiley +1 more source
Researches on the Inhibition Produced by certain Sera on the Coagulating Power of Rennet [PDF]
A. C. Thaysen
openalex +1 more source